{"ATC Code":"N - Nervous system","Abbreviation":"","Aliases":["Adinazolamum","U 41123","8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine","U-41123","U-41,123","4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine-1-methanamine, 8-chloro-N-N-dimethyl-6-phenyl-","8-chloro-1-[(dimethylamino)methyl]-6-phenyl-4h-s-triazolo[4,3-a][1,4]benzodiazepine","({12-chloro-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaen-3-yl}methyl)dimethylamine","((12-chloro-9-phenyl-2,4,5,8-tetraazatricyclo(8.4.0.0^(2,6))tetradeca-1(10),3,5,8,11,13-hexaen-3-yl)methyl)dimethylamine","1-(8-chloro-6-phenyl-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepin-1-yl)-N,N-dimethylmethanamine"],"Biological Half-Life":"Less than 3 hours.","CAS":"37115-32-5","ChEBI":"CHEBI:251412","ChEMBL":"CHEMBL328250","ChemicalClasses":["triazolobenzodiazepine"],"Chirality":"achiral","Classes":null,"Drug Indication":"For the treatment of anxiety and status epilepticus.","DrugClasses":["antidepressant","depressant"],"EliminationHalfLife":"\u003c 3 hours","Erowid Experience Reports":[],"FullSalts":["Adinazolam mesylate"],"HMDB ID":"HMDB0014686","HeavyAtomCount":25,"IUPACName":"1-(8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine","InChI":"InChI=1S/C19H18ClN5/c1-24(2)12-18-23-22-17-11-21-19(13-6-4-3-5-7-13)15-10-14(20)8-9-16(15)25(17)18/h3-10H,11-12H2,1-2H3","InChIKey":"GJSLOMWRLALDCT-UHFFFAOYSA-N","MeSH Pharmacological Classification":"Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)","MolecularFormula":"C\u003csub\u003e19\u003c/sub\u003eH\u003csub\u003e18\u003c/sub\u003eClN\u003csub\u003e5\u003c/sub\u003e","MolecularWeight":"351.8 g/mol","Pharmacodynamics":"Adinazolam is a benzodiazepine derivative used to treat anxiety, status epilepticus, and for sedation induction and anterograde amnesia. Adinazolam binds with high affinity to the GABA benzodiazepine receptor complex. Considerable evidence suggest that the central pharmacologic/therapeutic actions of alprazolam are mediated via interaction with this receptor complex.","Physical Description":"Solid","PrevSalts":["mesylate"],"PubChemId":37632,"Record Description":["Adinazolam is a triazolo[4,3-a][1,4]benzodiazepine having a dimethylaminomethyl group at the 1-position, a phenyl group at the 6-position and a chloro substituent at the 8-position. It has a role as a sedative, an anxiolytic drug, an anticonvulsant and an antidepressant.","Adinazolam (Deracyn®) is a benzodiazepine derivative with anxiolytic, anticonvulsant, sedative, and antidepressant properties. Adinazolam was first developed to enhance the antidepressant effects of [alprazolam]. It has never been approved by the FDA for clinical use.","ADINAZOLAM is a small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication.","Adinazolam is a triazolo[4,3-a][1,4]benzodiazepine having a dimethylaminomethyl group at the 1-position, a phenyl group at the 6-position and a chloro substituent at the 8-position. It has a role as a sedative, an anxiolytic drug, an anticonvulsant and an antidepressant.","Wikipedia|List of designer drugs|Sedatives|Benzodiazepines"],"RefCount":3,"References":[{"Name":"Wikipedia","Urls":[{"Link":"https://en.wikipedia.org/wiki/Adinazolam","Name":"Adinazolam","Sub":false}]},{"Name":"Wikidata","Urls":[{"Link":"https://www.wikidata.org/wiki/Q4682904","Name":"Adinazolam","Sub":false}]},{"Name":"DrugBank","Urls":[{"Link":"https://go.drugbank.com/drugs/DB00546","Name":"Adinazolam","Sub":false}]},{"Name":"PubChem","Urls":[{"Link":"https://pubchem.ncbi.nlm.nih.gov/compound/37632","Name":"Adinazolam","Sub":false}]},{"Name":"ChEMBL","Urls":[{"Link":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL328250","Name":"Adinazolam","Sub":false}]},{"Name":"ChEBI","Urls":[{"Link":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:251412","Name":"Adinazolam","Sub":false}]},{"Name":"Common Chemistry","Urls":[{"Link":"https://commonchemistry.cas.org/detail?cas_rn=37115-32-5","Name":"Adinazolam","Sub":false}]},{"Name":"HMDB","Urls":[{"Link":"https://hmdb.ca/metabolites/HMDB0014686","Name":"Adinazolam","Sub":false}]},{"Name":"KEGG","Urls":[{"Link":"https://www.kegg.jp/entry/D02770","Name":"Adinazolam","Sub":false}]},{"Name":"UNII","Urls":[{"Link":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/KN08449444","Name":"Adinazolam","Sub":false}]},{"Name":"EPA DSSTox","Urls":[{"Link":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID40190611","Name":"Adinazolam","Sub":false}]}],"Refs":["National Center for Biotechnology Information. PubChem Compound Summary for CID 37632, Adinazolam. Accessed June 26, 2025. \u003ca href=https://pubchem.ncbi.nlm.nih.gov/compound/37632\u003ehttps://pubchem.ncbi.nlm.nih.gov/compound/37632\u003c/a\u003e","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Adinazolam. UNII: KN08449444. Global Substance Registration System. Accessed June 26, 2025. \u003ca href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/KN08449444\u003ehttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/KN08449444\u003c/a\u003e"],"SMILES":"CN(C)CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4","Salts":["mesylate"],"SaltsAcidCount":[0],"SaltsAmineCount":[1],"SaltsUNII":["NT8S62A727"],"Scheduling":[{"gov":"Australia","ref":[],"schedule":"S4 substance"},{"gov":"Canada","ref":[],"schedule":"Schedule IV substance"},{"gov":"Brazil","ref":[],"schedule":"B1 substance"},{"act":"Neue-psychoaktive-Stoffe-Gesetz (NpSG)","gov":"Germany","ref":[],"schedule":"Neuer-Psychoaktiver-Stoff"},{"gov":"United Kingdom","ref":[],"schedule":"Class C substance"},{"gov":"United States","ref":[],"schedule":"Unscheduled (Not FDA approved) substance"},{"gov":"United Nations","ref":[],"schedule":"Unscheduled substance"}],"Solubility":"6.72e-02 g/L","StoreUNII":["KN08449444"],"StructureBase64":"<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" height="127.177mm" version="1.2" viewBox="0 0 82.075 127.177" width="82.075mm">
      
    <desc>Generated by the Chemistry Development Kit (http://github.com/cdk)</desc>
      
    <g fill="#3050F8" stroke="#000000" stroke-linecap="round" stroke-linejoin="round" stroke-width=".7">
            
        <rect fill="#FFFFFF" height="128.0" stroke="none" width="83.0" x=".0" y=".0"/>
            
        <g class="mol" id="mol1">
                  
            <line class="bond" id="mol1bnd1" x1="29.748" x2="39.659" y1="1.041" y2="7.018"/>
                  
            <line class="bond" id="mol1bnd2" x1="45.965" x2="56.14" y1="7.163" y2="1.546"/>
                  
            <line class="bond" id="mol1bnd3" x1="42.725" x2="42.507" y1="12.761" y2="24.149"/>
                  
            <line class="bond" id="mol1bnd4" x1="42.507" x2="55.557" y1="24.149" y2="32.02"/>
                  
            <g class="bond" id="mol1bnd5">
                        
                <line x1="66.367" x2="55.557" y1="27.455" y2="32.02"/>
                        
                <line x1="67.316" x2="58.138" y1="29.701" y2="33.577"/>
                      
                <line class="hi" stroke="#3050F8" x1="66.367" x2="60.962" y1="27.455" y2="29.7375"/>
                <line class="hi" stroke="#3050F8" x1="67.316" x2="62.727000000000004" y1="29.701" y2="31.639"/>
            </g>
                  
            <line class="bond" id="mol1bnd6" x1="72.455" x2="76.717" y1="29.39" y2="34.313"/>
                  
            <g class="bond" id="mol1bnd7">
                        
                <line x1="71.695" x2="77.371" y1="50.658" y2="41.261"/>
                        
                <line x1="70.524" x2="75.284" y1="47.882" y2="40.001"/>
                      
                <line class="hi" stroke="#3050F8" x1="77.371" x2="74.53299999999999" y1="41.261" y2="45.959500000000006"/>
                <line class="hi" stroke="#3050F8" x1="75.284" x2="72.904" y1="40.001" y2="43.9415"/>
            </g>
                  
            <line class="bond" id="mol1bnd8" x1="71.695" x2="60.166" y1="50.658" y2="47.974"/>
                  
            <line class="bond" id="mol1bnd9" x1="55.557" x2="56.531" y1="32.02" y2="43.359"/>
                  
            <line class="bond" id="mol1bnd10" x1="53.83" x2="44.975" y1="49.64" y2="56.754"/>
                  
            <g class="bond" id="mol1bnd11">
                        
                <line x1="44.975" x2="44.975" y1="71.994" y2="56.754"/>
                        
                <line x1="42.536" x2="42.536" y1="70.586" y2="58.163"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd12" x1="44.975" x2="31.767" y1="71.994" y2="79.614"/>
                  
            <g class="bond" id="mol1bnd13">
                        
                <line x1="18.559" x2="31.767" y1="71.994" y2="79.614"/>
                        
                <line x1="20.997" x2="31.767" y1="70.586" y2="76.799"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd14" x1="18.559" x2="18.559" y1="71.994" y2="56.754"/>
                  
            <g class="bond" id="mol1bnd15">
                        
                <line x1="31.767" x2="18.559" y1="49.134" y2="56.754"/>
                        
                <line x1="31.767" x2="20.997" y1="51.95" y2="58.163"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd16" x1="44.975" x2="31.767" y1="56.754" y2="49.134"/>
                  
            <line class="bond" id="mol1bnd17" x1="18.559" x2="6.875" y1="71.994" y2="78.743"/>
                  
            <line class="bond" id="mol1bnd18" x1="44.975" x2="56.862" y1="71.994" y2="81.545"/>
                  
            <g class="bond" id="mol1bnd19">
                        
                <line x1="56.862" x2="68.391" y1="81.545" y2="78.86"/>
                        
                <line x1="57.464" x2="67.838" y1="78.901" y2="76.485"/>
                      
                <line class="hi" stroke="#3050F8" x1="68.391" x2="62.62650000000001" y1="78.86" y2="80.2025"/>
                <line class="hi" stroke="#3050F8" x1="67.838" x2="62.650999999999996" y1="76.485" y2="77.693"/>
            </g>
                  
            <line class="bond" id="mol1bnd20" x1="73.482" x2="78.299" y1="74.379" y2="64.374"/>
                  
            <line class="bond" id="mol1bnd21" x1="71.695" x2="78.299" y1="50.658" y2="64.374"/>
                  
            <line class="bond" id="mol1bnd22" x1="56.862" x2="53.476" y1="81.545" y2="96.404"/>
                  
            <g class="bond" id="mol1bnd23">
                        
                <line x1="64.662" x2="53.476" y1="106.768" y2="96.404"/>
                        
                <line x1="61.971" x2="52.851" y1="107.599" y2="99.149"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd24" x1="64.662" x2="61.276" y1="106.768" y2="121.627"/>
                  
            <g class="bond" id="mol1bnd25">
                        
                <line x1="46.705" x2="61.276" y1="126.122" y2="121.627"/>
                        
                <line x1="47.331" x2="59.211" y1="123.378" y2="119.712"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd26" x1="46.705" x2="35.52" y1="126.122" y2="115.759"/>
                  
            <g class="bond" id="mol1bnd27">
                        
                <line x1="38.906" x2="35.52" y1="100.9" y2="115.759"/>
                        
                <line x1="40.97" x2="38.21" y1="102.814" y2="114.927"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd28" x1="53.476" x2="38.906" y1="96.404" y2="100.9"/>
                  
            <path class="atom" d="M44.739 11.361h-.72l-2.62 -4.066h-.029q.012 .239 .029 .596q.024 .357 .024 .732v2.738h-.565v-4.899h.714l2.608 4.054h.029q-.006 -.107 -.017 -.327q-.012 -.221 -.024 -.477q-.006 -.262 -.006 -.482v-2.768h.577v4.899z" id="mol1atm2" stroke="none"/>
                  
            <path class="atom" d="M71.538 28.54h-.72l-2.619 -4.066h-.03q.012 .238 .03 .595q.023 .358 .023 .733v2.738h-.565v-4.899h.714l2.608 4.054h.03q-.006 -.107 -.018 -.328q-.012 -.22 -.024 -.476q-.006 -.262 -.006 -.482v-2.768h.577v4.899z" id="mol1atm6" stroke="none"/>
                  
            <path class="atom" d="M81.515 40.063h-.72l-2.62 -4.066h-.03q.012 .238 .03 .595q.024 .357 .024 .732v2.739h-.566v-4.9h.715l2.607 4.055h.03q-.006 -.108 -.018 -.328q-.012 -.22 -.024 -.476q-.006 -.262 -.006 -.482v-2.769h.578v4.9z" id="mol1atm7" stroke="none"/>
                  
            <path class="atom" d="M58.802 49.654h-.72l-2.619 -4.066h-.03q.012 .238 .03 .595q.024 .357 .024 .732v2.739h-.566v-4.9h.714l2.608 4.054h.03q-.006 -.107 -.018 -.327q-.012 -.22 -.024 -.476q-.006 -.262 -.006 -.482v-2.769h.577v4.9z" id="mol1atm9" stroke="none"/>
                  
            <path class="atom" d="M2.906 77.801q-.786 -.0 -1.239 .53q-.452 .524 -.452 1.446q-.0 .911 .417 1.447q.422 .53 1.268 .53q.321 -.0 .607 -.054q.292 -.059 .565 -.143v.536q-.273 .101 -.565 .149q-.292 .053 -.697 .053q-.744 .0 -1.25 -.309q-.5 -.31 -.75 -.875q-.25 -.572 -.25 -1.34q.0 -.744 .268 -1.309q.274 -.566 .804 -.881q.529 -.322 1.279 -.322q.78 .0 1.352 .286l-.244 .524q-.226 -.101 -.506 -.185q-.274 -.083 -.607 -.083zM5.662 82.224h-.601v-5.215h.601v5.215z" fill="#1FF01F" id="mol1atm16" stroke="none"/>
                  
            <path class="atom" d="M73.636 80.54h-.72l-2.62 -4.066h-.029q.012 .238 .029 .595q.024 .358 .024 .733v2.738h-.565v-4.899h.714l2.607 4.054h.03q-.006 -.107 -.018 -.328q-.012 -.22 -.023 -.476q-.006 -.262 -.006 -.482v-2.768h.577v4.899z" id="mol1atm18" stroke="none"/>
                
            <line class="hi" id="mol1bnd1" stroke="#3050F8" x1="39.659" x2="34.7035" y1="7.018000000000001" y2="4.0295"/>
            <line class="hi" id="mol1bnd2" stroke="#3050F8" x1="45.965" x2="51.0525" y1="7.163" y2="4.3545"/>
            <line class="hi" id="mol1bnd3" stroke="#3050F8" x1="42.725" x2="42.616" y1="12.761" y2="18.455"/>
            <line class="hi" id="mol1bnd6" stroke="#3050F8" x1="72.455" x2="74.586" y1="29.39" y2="31.8515"/>
            <line class="hi" id="mol1bnd6" stroke="#3050F8" x1="76.717" x2="74.586" y1="34.313" y2="31.8515"/>
            <line class="hi" id="mol1bnd8" stroke="#3050F8" x1="60.166" x2="65.9305" y1="47.974" y2="49.316"/>
            <line class="hi" id="mol1bnd9" stroke="#3050F8" x1="56.531" x2="56.044" y1="43.359" y2="37.6895"/>
            <line class="hi" id="mol1bnd10" stroke="#3050F8" x1="53.83" x2="49.4025" y1="49.64" y2="53.197"/>
            <line class="hi" id="mol1bnd17" stroke="#1FF01F" x1="6.875" x2="12.717" y1="78.743" y2="75.3685"/>
            <line class="hi" id="mol1bnd20" stroke="#3050F8" x1="73.482" x2="75.8905" y1="74.379" y2="69.3765"/>
        </g>
          
    </g>
    
</svg>
","Subjective Effects":null,"Title":"Adinazolam","UNII":"KN08449444","Wikidata":"Q4682904","Wikipedia":"Adinazolam","XLogP":1.6}